
GRAIL is a healthcare company focused on developing a multi-cancer early detection blood test capable of screening for over 50 types of cancer before symptoms manifest. This platform utilizes advanced techniques such as next-generation sequencing, data science, and machine learning to identify a shared cancer signal within DNA present in the bloodstream.